Cellect Biotechnology (APOP) Reports Positive Results from 20 Patients Trial with Tel-Aviv Ichilov Medical Center
Tweet Send to a Friend
Cellect Biotechnology Ltd. (NASDAQ: APOP) announced today that it has achieved a major milestone with the conclusion of a large ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE